doi:10.1592/phco.22.12.1067.33602
Modern Research makes no claims that its products diagnose, treat, cure, mitigate, or prevent any disease or medical condition
Inter-species differences in drug metabolism, immune responses, and liver regeneration capacity can affect the translatability of findings, thereby restricting the extrapolation of preclinical data to clinical settings
What The FDA Category 1 vs Category 2 Status Means Today Under the FDAs interim bulk substances framework for 503A compounding pharmacies: Category 1: Bulk Drug Substances under evaluation with sufficient supporting safety information
The "rapid reversal" group (approximately 10-15% of users) experiences concerning quick benefit loss within weeks of discontinuation, typically involving users who applied very high concentrations creating dependency-like patterns, possessed severe underlying skin conditions requiring ongoing treatment, experienced significant lifestyle or environmental stressors overwhelming skin resilience, discontinued abruptly without tapering from high-dose protocols, or had unrealistic perception inflation during treatment leading to exaggerated reversal perception